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HEALTHCARE CHALLENGE BEING TACKLED RESULTS
In 2019, the Center for Disease Control (CDC) reported 70,980
deaths attributed to drug overdose, a 4.5% nationwide increase
over 12-months.
A disproportionate amount of these deaths occurred in Arizona,
which saw a 14.5% increase in mortality over the same time period.
Although physician prescribing habits have developed, the need
remains to improve physician education on opioid use disorder
(OUD) and safe prescribing habits.
Most primary care physicians are reluctant to prescribe
buprenorphine as gaps in provider education and a persistent
stigma toward patients with OUD remain.
Between February – November, the MAT-ECHO program has hosted N=20
teleECHO sessions with 255 unique participating providers and delivered
877 learning hours (Fig 1).
The six-month post-ECHO survey was sent to all teleECHO participants in
the program (N=247). 13 teleECHO participants completed the survey in
its entirety. Participants reported an average of 12 years of experience
(Table 1). The majority (38%) held NP/PA professional degrees and
practiced in OTP clinic settings (54%) (Table 1). Participants originated
from California, Arizona, and Ohio. (Fig 2). The majority of participants
who completed the survey data attended multiple sessions (Table 1, Fig
3)
Assessment of job satisfaction and well-being revealed overall improved
satisfaction among the small cohort of non-waivered respondents (N=8),
with the exception of the ability to meet patients’ needs. MAT-waivered
respondents reported no post-session changes (Table 3).Arizona State University and HonorHealth developed the
Medication-Assisted Treatment (MAT) ECHO.
Project ECHO connects an interdisciplinary team of experts with
local clinicians through biweekly, virtual teleECHO™ clinics. Experts
share specialized knowledge across the learning network by
leveraging proven adult-learning modalities and real-patient case
consultation.
This enables clinicians to retain care of their own patients while
increasing capacity and confidence to treat patients with OUD.
Participants are not required to have a MAT waiver but are
encouraged to pursue training. HonorHealth IRB deemed the study
Exempt.
Participants engage in biweekly, virtual teleECHO™ sessions.
Post-session surveys are disseminated to collect data on provider
satisfaction, self-efficacy, knowledge, barriers to change and
changes in practice behavior.
A pre-post survey is disseminated at 6-month increments to gather
further understanding of the programmatic impacts on provider
capacity, confidence, and changes in practice patterns.
Survey questionnaire structure: clinical credentials, years of clinical
practice, work setting, number of sessions attended, knowledge
about treatment of substance use disorder before and after session,
Limitations include a low response rate. Program leadership report a regular
cadre of 38-52 participants who attend the teleECHO sessions (Fig 1), which
may reflect a more accurate response rate.
These preliminary data merit additional investigation; specifically, increasing
the number of MAT-waivered participants; facilitating interdisciplinary
mentorship and partnership to enhance job and career satisfaction; and
continuing to increase visibility of the community network of care for
patients with SUD.
Implementation of an ECHO program focused on improving access to care for
patients with OUD may lead to fewer emergency department visits and
hospitalizations. Investment in upstream initiatives (e.g. education programs)
improves health outcomes and the health of the population and increased
public health spending correlates with decreased mortality.
Community partnerships that invest in effective and preventive management
of patients with OUD will decrease the cost burden on patients and health
care systems and improve patient-centered care.
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Figure 1: Attendance per teleECHO session
Table 2: Knowledge and confidence of participants, 
before and since attending teleECHO
Figure 2. Geographic representation of teleECHO 
participants
Table 3. Participant well-being and job satisfaction, 
before and since attending teleECHO, non-waivered 
participants
Figure 4: Respondents ranking of their knowledge about 
various topics before and after attending MAT-ECHO 
sessions. SUD = Substance use disorder, OUD = Opioid use 
disorder. ** indicates p < 0.01, *** indicates p < 0.001
